Last Updated:
10 Mar 2026, 03:29:06 PM (IST)
Procter & Gamble Health Limited
NSE: PGHL BSE: PGHL
NSE
4,892.10
58.70 (1.21%)
Prev Close
4833.4
Open Price
4851
Volume
11,986
Today Low / High
4826.9 / 4939
52 WK Low / High
4780 / 6739
Range
4,647 - 5,137
BSE
4,894.20
59.45 (1.23%)
Prev Close
4834.75
Open Price
4850
Volume
503
Today Low / High
4828.6 / 4932.15
52 WK Low / High
4781 / 6700
Range
4,649 - 5,139
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 4892.1 (target range: 4,647 - 5,137), reflecting a change of 58.7 (1.21447%). On the BSE, it is listed at 4894.2 (target range: 4,649 - 5,139), showing a change of 59.45 (1.22964%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
02 Mar
4,949.00
0.78%
27 Feb
5,123.00
-4.34%
26 Feb
5,160.00
-0.70%
25 Feb
5,118.50
0.34%
24 Feb
5,050.00
2.20%
23 Feb
5,030.00
0.95%
20 Feb
5,017.50
0.04%
19 Feb
5,016.00
0.03%
18 Feb
5,090.00
-1.41%
Procter & Gamble Health Limited Graph
Procter & Gamble Health Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Procter & Gamble Health Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 4,892.10, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 4,894.20 | 4,943.14 | 4,448.83 - 5,437.46 |
| 4,992.08 | 3,993.67 - 5,990.50 | ||
| 5,041.03 | 3,528.72 - 6,553.33 | ||
| Bearish Scenario | 4,894.20 | 4,845.26 | 4,360.73 - 5,329.78 |
| 4,796.32 | 3,837.05 - 5,755.58 | ||
| 4,747.37 | 3,323.16 - 6,171.59 |
Overview of Procter & Gamble Health Limited
ISIN
INE199A01012
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
12,376
Market Cap
82,791,077,663
Last Dividend
220
Official Website
IPO Date
2002-07-01
DCF Diff
-10,769.71
DCF
16,165
Financial Ratios Every Investor Needs
Stock Dividend of PGHL
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2026-02-12 | February 12, 26 | 160 | 160 | 2026-02-12 | 2026-03-04 | |
| 2025-08-22 | August 22, 25 | 45 | 45 | 2025-08-22 | 2025-09-25 | |
| 2025-02-21 | February 21, 25 | 80 | 80 | 2025-02-21 | 2025-03-07 | |
| 2024-11-28 | November 28, 24 | 60 | 60 | 2024-11-28 | 2024-12-25 | |
| 2024-02-14 | February 14, 24 | 200 | 200 | 2024-02-14 | 2024-03-03 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,218.05 Cr | 348.97 Cr | 869.08 Cr | 0.7135 | 2.61 Cr | 190.97 Cr | 633.17 Cr | 251.19 Cr | 151.33 | 362.09 Cr | 0.2062 |
| 2024-03-31 | 1,151.26 Cr | 342.54 Cr | 808.72 Cr | 0.7025 | 3.86 Cr | 215.53 Cr | 536.68 Cr | 200.98 Cr | 121.08 | 303.41 Cr | 0.1746 |
| 2023-03-31 | 1,229.62 Cr | 383.37 Cr | 846.25 Cr | 0.6882 | 5.71 Cr | 206.64 Cr | 559.41 Cr | 229.47 Cr | 138.24 | 318.75 Cr | 0.1866 |
| 2022-03-31 | 1,114.41 Cr | 353.05 Cr | 761.36 Cr | 0.6832 | 6.55 Cr | 168.19 Cr | 477.17 Cr | 192.52 Cr | 115.98 | 264.77 Cr | 0.1728 |
| 2021-03-31 | 1,008.73 Cr | 324.51 Cr | 684.22 Cr | 0.6783 | 3.93 Cr | 155.19 Cr | 437.69 Cr | 176.80 Cr | 106.51 | 242.40 Cr | 0.1753 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 188.55 Cr | 794.20 Cr | 257.24 Cr | 536.9600 Cr | 7.62 Cr | -180.93 Cr | 109.37 Cr | 121.99 Cr | 0.00 Cr | 0.00 Cr | 19.33 Cr | 215.3100 Cr |
| 2024-06-30 | 244.36 Cr | 794.36 Cr | 256.12 Cr | 538.2400 Cr | 9.56 Cr | -234.80 Cr | 109.11 Cr | 131.53 Cr | 0.00 Cr | 0.00 Cr | 11.64 Cr | 218.9100 Cr |
| 2023-06-30 | 435.05 Cr | 1,101.19 Cr | 350.30 Cr | 750.8900 Cr | 12.00 Cr | -423.05 Cr | 134.94 Cr | 173.27 Cr | 54.82 Cr | 0.00 Cr | -12.64 Cr | 303.9000 Cr |
| 2022-06-30 | 319.40 Cr | 893.72 Cr | 277.23 Cr | 616.4900 Cr | 2.83 Cr | -316.57 Cr | 115.21 Cr | 149.62 Cr | 0.56 Cr | 0.00 Cr | -3.83 Cr | 235.8300 Cr |
| 2021-06-30 | 464.05 Cr | 986.16 Cr | 282.45 Cr | 703.7100 Cr | 7.61 Cr | -456.44 Cr | 118.37 Cr | 140.13 Cr | 97.22 Cr | 0.00 Cr | -2.66 Cr | 238.9700 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 175.8400 Cr | 2.4400 Cr | -234.7400 Cr | 167.2800 Cr | -251.6700 Cr | 188.5500 Cr | -8.5600 Cr | 312.5459 Cr | 0.0000 Cr | -232.4000 Cr | -2.3700 Cr |
| 2024-06-30 | 228.2800 Cr | -6.8700 Cr | -418.1100 Cr | 206.5600 Cr | -196.6900 Cr | 238.7300 Cr | -21.7300 Cr | 200.9800 Cr | 0.0000 Cr | -414.9900 Cr | 23.1300 Cr |
| 2023-06-30 | 236.0000 Cr | -21.5000 Cr | -98.4700 Cr | 193.5200 Cr | 116.0200 Cr | 435.4200 Cr | -42.4800 Cr | 314.2000 Cr | 0.0000 Cr | -93.7900 Cr | -32.3900 Cr |
| 2022-06-30 | 169.5200 Cr | -25.5400 Cr | -288.6300 Cr | 131.6000 Cr | -144.6500 Cr | 319.4000 Cr | -37.9200 Cr | 253.3700 Cr | 0.0000 Cr | -283.8500 Cr | -2.0200 Cr |
| 2021-06-30 | 247.2600 Cr | -32.2700 Cr | -386.6300 Cr | 194.6800 Cr | -171.6400 Cr | 464.0500 Cr | -52.5800 Cr | 233.2800 Cr | 0.0000 Cr | -381.7800 Cr | 15.2600 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 373.86 Cr | 177.53 Cr | 196.33 Cr | 0.5251 | 104.56 Cr | 77.59 Cr | 46.74 | 114.82 Cr | 0.2075 |
| 2025-09-30 | 324.92 Cr | 128.36 Cr | 196.56 Cr | 0.6049 | 114.19 Cr | 88.54 Cr | 53.34 | 125.22 Cr | 0.2725 |
| 2025-06-30 | 338.74 Cr | 93.99 Cr | 244.75 Cr | 0.7225 | 188.74 Cr | 66.18 Cr | 39.87 | 90.34 Cr | 0.1954 |
| 2025-03-31 | 310.99 Cr | 98.72 Cr | 212.27 Cr | 0.6826 | 163.48 Cr | 61.18 Cr | 36.86 | 80.92 Cr | 0.1967 |
| 2024-12-31 | 309.77 Cr | 75.73 Cr | 234.04 Cr | 0.7555 | 186.99 Cr | 90.90 Cr | 54.76 | 123.54 Cr | 0.2934 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 286.17 Cr | 0.00 Cr | 286.17 Cr | 139.18 Cr | 127.33 Cr | 639.26 Cr | 114.24 Cr | 894.40 Cr | 274.67 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 188.55 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -536.96 Cr |
| 2025-03-31 | 182.08 Cr | 23.98 Cr | 206.06 Cr | 146.99 Cr | 109.37 Cr | 526.39 Cr | 121.99 Cr | 794.20 Cr | 257.24 Cr |
| 2024-12-31 | 266.43 Cr | 25.83 Cr | 292.26 Cr | 132.24 Cr | 118.78 Cr | 612.49 Cr | 125.27 Cr | 870.15 Cr | 259.69 Cr |
| 2024-09-30 | 0.00 Cr | 0.00 Cr | 244.36 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -538.24 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 66.18 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 78.53 Cr | 49.22 Cr | -0.05 Cr | -133.58 Cr | -84.41 Cr | 182.27 Cr | 266.68 Cr | -3.23 Cr | 45.99 Cr |
| 2024-12-31 | 90.90 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 82.33 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 16.78 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,812.80 | ₹4,349,514,433,616.00 | ₹3,298,187.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,372.00 | ₹1,691,565,791,760.00 | ₹298,134.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,427.80 | ₹1,498,568,719,232.00 | ₹373,853.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,314.60 | ₹1,094,510,791,983.00 | ₹2,328,593.00 |
| Lupin Limited | LUPIN | ₹2,337.40 | ₹1,068,292,308,200.00 | ₹1,118,737.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹923.10 | ₹928,854,596,169.00 | ₹548,985.00 |
| Mankind Pharma Limited | MANKIND | ₹2,237.70 | ₹923,733,909,614.00 | ₹1,043,890.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,285.90 | ₹746,852,807,016.00 | ₹2,197,557.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,616.50 | ₹671,536,822,500.00 | ₹127,559.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,225.80 | ₹628,122,560,672.00 | ₹1,554,299.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,038.00 | ₹560,371,132,116.00 | ₹1,367,251.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,491.20 | ₹378,323,729,882.00 | ₹56,999.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,999.90 | ₹374,794,378,438.00 | ₹123,025.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,117.40 | ₹339,967,004,084.00 | ₹706,890.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,567.80 | ₹297,211,828,212.00 | ₹871,597.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,815.50 | ₹220,387,500,000.00 | ₹3,477.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,327.40 | ₹215,692,105,131.00 | ₹576,727.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹1,039.20 | ₹186,130,976,904.00 | ₹2,029,982.00 |
| Eris Lifesciences Limited | ERIS | ₹1,351.10 | ₹184,042,641,430.00 | ₹100,690.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹12,597.00 | ₹161,618,111,733.00 | ₹24,766.00 |
| Granules India Limited | GRANULES | ₹581.30 | ₹141,063,489,700.00 | ₹712,670.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹712.35 | ₹140,021,741,381.00 | ₹50,451.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹812.35 | ₹128,651,664,788.00 | ₹293,109.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,684.10 | ₹128,011,297,234.00 | ₹43,345.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹940.65 | ₹115,451,618,400.00 | ₹42,515.00 |
| Cohance Lifesciences Limited | COHANCE | ₹295.60 | ₹113,086,846,584.00 | ₹907,550.00 |
| Viyash Scientific Limited | VIYASH | ₹197.45 | ₹86,151,137,188.00 | ₹1,162,070.00 |
| Procter & Gamble Health Limited | PGHL | ₹4,892.10 | ₹81,205,836,682.00 | ₹11,986.00 |
| Strides Pharma Science Limited | STAR | ₹872.90 | ₹80,457,562,051.00 | ₹160,822.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹500.60 | ₹76,642,890,235.00 | ₹265,090.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹338.65 | ₹66,233,781,988.00 | ₹758,443.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹686.70 | ₹62,254,676,925.00 | ₹118,363.00 |
| FDC Limited | FDC | ₹378.05 | ₹61,550,352,256.00 | ₹52,686.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹124.37 | ₹40,360,749,900.00 | ₹1,617,219.00 |
| Innova Captab Limited | INNOVACAP | ₹703.35 | ₹40,249,153,812.00 | ₹21,279.00 |
| Suven Life Sciences Limited | SUVEN | ₹144.43 | ₹33,500,801,218.00 | ₹421,279.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹301.45 | ₹32,847,579,134.00 | ₹64,137.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹353.45 | ₹32,259,381,500.00 | ₹243,536.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,908.60 | ₹31,566,364,029.00 | ₹7,443.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹289.65 | ₹29,046,827,863.00 | ₹71,884.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹509.55 | ₹25,843,919,953.00 | ₹191,509.00 |
Key Executives
MD & Executive Director
Milind Vasant Thatte
Gender: male
Year Born: 1969
CFO & Executive Director
Shashank Srowthy
Gender: male
Year Born:
Director of Sales, Distributor Operations & Sales Stewardship Leader
Vishal Naik
Gender: male
Year Born:
Assistant Company Secretary
Prachi Vichare
Gender: female
Year Born:
Human Resource Leader
Sanika Gokhale
Gender: female
Year Born:
Compliance Officer & Company Secretary
Zeal Bhavin Rupani
Gender: female
Year Born:
FAQs about Procter & Gamble Health Limited
Who is the CEO of the company?
The CEO is Milind Vasant Thatte.
What is the current market price of the stock?
The current price is ₹4,987.60.
What is the 52-week price range?
The range is ₹4841.1-6739.
What is the market capitalization of the company?
The market capitalization is ₹8,279.11 crores.
What is the dividend yield?
The dividend yield is 4.11%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 28.21.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Procter & Gamble Health Limited (ISIN: INE199A01012) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹8,279.11 crores and an average daily volume of 12,376 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹220.